About this trial
Severe and persistent mental health disorders are associated with impairments in cognitive, emotional, and social functioning. Some of these disorders involve cognitive challenges that are likely to negatively affect quality of life. In this context, the early identification of cognitive difficulties and intervention through cognitive remediation become priority therapeutic targets to facilitate individual rehabilitation. From this perspective, the present study aims to determine the relevance of a personalized cognitive remediation program developed by neuropsychologists at Pierre-Janet Hospital, called RECAMEX, to guide its sustainable adoption and to support its implementation in other clinical settings.
Eligibility criteria
Qualifiers
Aged 18 years or older.
Present cognitive difficulties in the context of a diagnosed severe and persistent mental illness.
Report recurrent complaints related to cognitive challenges affecting multiple areas of daily functioning.
Able to provide free and informed consent.
Disqualifiers
Intellectual disability diagnosis and confirmed in medical record.
A major medical condition other than the mental health disorder that affects cognitive functioning.
Trial design
Treatments tested in this trial
- Cognitive remediation